1. Kulkarni A, Kelkar DA, Parikh N, Shashidhara LS, Koppiker CB, Kulkarni M. Meta-analysis of prevalence of triple-negative breast cancer and its clinical features at incidence in Indian patients with breast cancer. JCO global oncology. 2020 Jul; 6: 1052-62.
2. Barroso-Sousa R, Jain E, Cohen O, Kim D,
Buendia-Buendia J, Winer E, Lin N, Tolaney SM, Wagle N. Prevalence and mutational determinants of high tumor mutation burden in breast cancer. Annals of Oncology. 2020 Mar 1; 31(3): 387-94.
3. Burguin A, Diorio C, Durocher F. Breast cancer treatments: updates and new challenges. Journal of personalized medicine. 2021 Aug 19; 11(8): 808.
4. Yuen S, Monzawa S, Yanai S, Matsumoto H, Yata Y, Ichinose Y, Deai T, Hashimoto T, Tashiro T, Yamagami K. The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and
T2-weighted images. Breast Cancer. 2020 Sep; 27: 1029-37.
5. Iima M, Honda M, Sigmund EE, Ohno Kishimoto A, Kataoka M, Togashi K. Diffusion MRI of the breast: Current status and future directions. Journal of Magnetic Resonance Imaging. 2020 Jul; 52(1):
70-90.
6. Meyer HJ, Wienke A, Surov A. Diffusion-weighted imaging of different breast cancer molecular subtypes: a systematic review and meta-analysis. Breast Care. 2022 Feb 17; 17(1): 47-54.
7. Hottat NA, Badr DA, Lecomte S, Besse-Hammer T, Jani JC, Cannie MM. Value of diffusion-weighted MRI in predicting early response to neoadjuvant chemotherapy of breast cancer: Comparison between ROI-ADC and whole-lesion-ADC measurements. European radiology. 2022 Jun; 32(6): 4067-78.
8. Ha SM, Chang JM, Lee SH, Kim ES, Kim SY, Cho N, Moon WK. Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer.
Breast Cancer Research and Treatment. 2020 Jul; 182: 283-97.
9. Sammut SJ, Crispin-Ortuzar M, Chin SF,
Provenzano E, Bardwell HA, Ma W, Cope W, Dariush A, Dawson SJ, Abraham JE, Dunn J.
Multi-omic machine learning predictor of breast cancer therapy response. Nature. 2022 Jan 27; 601(7894): 623-9.
10. Giess CS, Poole PS, Chikarmane SA, Sippo DA, Birdwell RL. Screening breast MRI in patients previously treated for breast cancer: diagnostic yield for cancer and abnormal interpretation rate. Academic radiology. 2015 Nov 1; 22(11): 1331-7.
11. Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Romanoff J, Cimino L, Joe BN. Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial. Radiology. 2018 Dec; 289(3): 618-27.
12. Amornsiripanitch N, Bickelhaupt S, Shin HJ, Dang M, Rahbar H, Pinker K, Partridge SC.
Diffusion-weighted MRI for unenhanced
breast cancer screening. Radiology. 2019 Dec; 293(3): 504-20.
13. Hottat NA, Badr DA, Lecomte S, Besse-Hammer T, Jani JC, Cannie MM. Value of diffusion-weighted MRI in predicting early response to
neoadjuvant chemotherapy of breast cancer: Comparison between ROI-ADC and
whole-lesion-ADC measurements. European radiology. 2022 Jun; 32(6): 4067-78.
14. Rotili A, Trimboli RM, Penco S, Pesapane F, Tantrige P, Cassano E, Sardanelli F. Double reading of diffusion-weighted magnetic resonance imaging for breast cancer detection. Breast cancer research and treatment. 2020 Feb; 180: 111-20.
15. Avendano D, Marino MA, Leithner D,
Thakur S, Bernard-Davila B, Martinez DF,
Helbich TH, Morris EA, Jochelson MS, Baltzer PA, Clauser P. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI. Breast Cancer Research. 2019 Dec; 21: 1-0.
16. Pinker K, Moy L, Sutton EJ, Mann RM, Weber M, Thakur SB, Jochelson MS, Bago-Horvath Z, Morris EA, Baltzer PA, Helbich TH. Diffusion-weighted imaging with apparent diffusion coefficient
mapping for breast cancer detection as a stand-alone parameter: comparison with dynamic
contrast-enhanced and multiparametric magnetic resonance imaging. Investigative radiology. 2018 Oct 1; 53(10): 587-95.
17. Surov A, Meyer HJ, Wienke A. Can apparent diffusion coefficient (ADC) distinguish breast
cancer from benign breast findings? A meta-analysis based on 13 847 lesions. BMC cancer. 2019
Dec; 19: 1-4.
18. Ding JR, Wang DN, Pan JL. Apparent
diffusion coefficient value of diffusion-weighted imaging for differential diagnosis of ductal carcinoma in situ and infiltrating ductal carcinoma. Journal of cancer research and therapeutics. 2016 Apr 1; 12(2): 744-50.
19. Islam MM, Haque MR, Iqbal H, Hasan MM, Hasan M, Kabir MN. Breast cancer prediction: a comparative study using machine
learning techniques. SN Computer Science. 2020 Sep; 1: 1-4.
20. Yue W, Wang Z, Chen H, Payne A, Liu X.
Machine learning with applications in
breast cancer diagnosis and prognosis. Designs.
2018 May 9; 2(2): 13.
21. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988 Aug; 168(2): 497-505.
